Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell Disease

外周敏化作为镰状细胞病疼痛的新机制

基本信息

  • 批准号:
    9304263
  • 负责人:
  • 金额:
    $ 16.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-15 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to provide the applicant a pathway to independence as a clinical investigator and expert in the field of pain in sickle cell disease (SCD). Pain causes significant morbidity for patients with SCD and currently there is a gap in knowledge in the understanding of SCD pain. This knowledge gap has hindered the development of new treatments for SCD pain. Thus, the overarching career goals of the applicant are to begin to close this knowledge gap by dedicating her career to the study of SCD pain. The applicant strives to become an expert in SCD pain and to develop and apply novel interventions for SCD pain management and/or prevention. She will begin to achieve these goals by performing patient-oriented research focused on SCD pain and engaging in career development activities focused on training in pain from clinical, biological, and research perspectives. Specifically, she will require additional training in the fundamental concepts of pain neurobiology, methodology of pain research, and further training in the management of both acute and chronic pain. Her career development plan is specifically tailored to her training needs in pediatric pain and will be guided by mentors and a scientific advisory committee at the Medical College of Wisconsin. The training plan takes advantage of training opportunities at the Medical College of Wisconsin and will also take advantage of opportunities outside of the institution to supplement her on-site pain training. The research activities will include investigation into the underlying neurobiology of SCD pain by exploration into mechanisms of peripheral sensitization and its contribution to SCD pain. Peripheral sensitization occurs when damage to or change in peripheral nerves result in features of neuropathic pain which can clinically present as hypersensitivity to mechanical or thermal stimuli. Preliminary data in both mice and patients with SCD reveal they both display hypersensitivity to heat and cold stimuli when in baseline state of health. In mice, this hypersensitivity worsens with hypoxia-reoxygenation, a laboratory-induced method that induces sickling phenomenon. It is not known whether this worsening sensitivity occurs in patients with SCD and the underlying reason for this hypersensitivity is not known. Chronic inflammation, including leukotrienes, has been shown to sensitize pain sensing nociceptors in non-SCD models. In addition, leukotrienes have been shown to be elevated in SCD patients compared to controls, increase further during acute pain, and higher levels have been associated with more frequent pain. The contribution of leukotrienes to peripheral sensitization in SCD has not been studied. Thus, this proposal aims to further study peripheral sensitization in humans with SCD using a validated methodology called quantitative sensory testing (QST) where thermal (heat, cold) pain thresholds can be safely and feasibly measured and will explore the association of leukotrienes with this sensitivity. We will use QST to evaluate heat and cold pain thresholds during an acute pain event and determine the relationship of leukotriene levels to these thermal pain thresholds at baseline and during pain. Results of this proposal have the potential to provide a mechanistic-based guide for further studies into the neurobiology of SCD pain and ultimately may contribute to the discovery of novel targets for therapeutics to prevent or treat SCD pain and relieve the suffering that patients with SCD experience.
描述(由申请人提供):该提案的目标是为申请人提供一条独立作为镰状细胞病(SCD)疼痛领域的临床研究者和专家的途径。疼痛导致 SCD 患者显着发病,目前对 SCD 疼痛的理解存在知识空白。这种知识差距阻碍了 SCD 疼痛新疗法的开发。因此,申请人的总体职业目标是通过将她的职业生涯奉献给 SCD 疼痛的研究来开始缩小这一知识差距。申请人努力成为 SCD 疼痛方面的专家,并开发和应用新的干预措施来管理和/或预防 SCD 疼痛。她将通过开展以患者为中心的以 SCD 疼痛为重点的研究,并参与以临床、生物学和研究角度的疼痛培训为重点的职业发展活动,开始实现这些目标。具体来说,她将需要接受有关疼痛神经生物学基本概念、疼痛研究方法的额外培训,以及急性和慢性疼痛管理方面的进一步培训。她的职业发展计划专门针对她在儿科疼痛方面的培训需求,并将受到威斯康星医学院的导师和科学咨询委员会的指导。培训计划利用了威斯康星医学院的培训机会,也将利用机构外的机会来补充她的现场疼痛培训。研究活动将包括通过探索外周敏化机制及其对 SCD 疼痛的影响来研究 SCD 疼痛的基础神经生物学。当周围神经损伤或变化导致神经性疼痛的特征时,就会发生周围敏化,神经性疼痛在临床上表现为对机械或热刺激的超敏反应。小鼠和 SCD 患者的初步数据显示,在健康基线状态下,它们都表现出对热和冷刺激的过敏反应。在小鼠中,这种超敏反应会因缺氧复氧而恶化,缺氧复氧是一种实验室诱导的方法,可诱发镰状现象。目前尚不清楚这种敏感性恶化是否发生在 SCD 患者中,而且这种过敏的根本原因尚不清楚。慢性炎症,包括白三烯,已被证明可以使非 SCD 模型中的疼痛感知伤害感受器敏感。此外,与对照组相比,SCD 患者的白三烯含量升高,在急性疼痛期间进一步升高,并且较高的水平与更频繁的疼痛相关。尚未研究白三烯对 SCD 外周敏化的影响。因此,本提案旨在使用一种称为定量感觉测试 (QST) 的有效方法进一步研究 SCD 患者的外周敏感性,其中可以安全可行地测量热(热、冷)疼痛阈值,并将探讨白三烯与这种敏感性的关联。我们将使用 QST 来评估急性疼痛事件期间的热痛阈值和冷痛阈值,并确定基线和疼痛期间白三烯水平与这些热痛阈值的关系。该提案的结果有可能为 SCD 疼痛的神经生物学的进一步研究提供基于机制的指导,并最终可能有助于发现预防或治疗 SCD 疼痛并减轻患者痛苦的治疗新靶点。 具有SCD经验。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay.
镰状细胞病儿童使用神经性止痛药与年龄较大、女性和住院时间较长有关。
  • DOI:
  • 发表时间:
    2015-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Brandow, Amanda M;Farley, Rebecca A;Dasgupta, Mahua;Hoffmann, Raymond G;Panepinto, Julie A
  • 通讯作者:
    Panepinto, Julie A
Update on the use of hydroxyurea therapy in sickle cell disease.
羟基脲治疗镰状细胞病的最新进展。
  • DOI:
  • 发表时间:
    2014-12-18
  • 期刊:
  • 影响因子:
    20.3
  • 作者:
    Wong, Trisha E;Brandow, Amanda M;Lim, Wendy;Lottenberg, Richard
  • 通讯作者:
    Lottenberg, Richard
Responsiveness of Patient-Reported Outcome Measurement Information System (PROMIS) pain domains and disease-specific patient-reported outcome measures in children and adults with sickle cell disease.
镰状细胞病儿童和成人患者报告结果测量信息系统 (PROMIS) 疼痛领域和特定疾病患者报告结果测量的反应性。
  • DOI:
  • 发表时间:
    2017-12-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Curtis, Susanna;Brandow, Amanda M
  • 通讯作者:
    Brandow, Amanda M
Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.
对镰状细胞病疼痛神经生物学的早期见解:文献的系统回顾。
  • DOI:
  • 发表时间:
    2015-09
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Brandow, Amanda M;Farley, Rebecca A;Panepinto, Julie A
  • 通讯作者:
    Panepinto, Julie A
Pain-measurement tools in sickle cell disease: where are we now?
镰状细胞病的疼痛测量工具:我们现在在哪里?
  • DOI:
  • 发表时间:
    2017-12-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Darbari, Deepika S;Brandow, Amanda M
  • 通讯作者:
    Brandow, Amanda M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amanda M Brandow其他文献

Amanda M Brandow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amanda M Brandow', 18)}}的其他基金

Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
  • 批准号:
    10311624
  • 财政年份:
    2021
  • 资助金额:
    $ 16.69万
  • 项目类别:
The Inflammatory Index as a Biomarker for Pain in Patients with Sickle Cell Disease
炎症指数作为镰状细胞病患者疼痛的生物标志物
  • 批准号:
    10618737
  • 财政年份:
    2019
  • 资助金额:
    $ 16.69万
  • 项目类别:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
研究微生物组和炎症在镰状细胞病患者急性和慢性疼痛中的作用
  • 批准号:
    10462603
  • 财政年份:
    2018
  • 资助金额:
    $ 16.69万
  • 项目类别:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
研究微生物组和炎症在镰状细胞病患者急性和慢性疼痛中的作用
  • 批准号:
    10000989
  • 财政年份:
    2018
  • 资助金额:
    $ 16.69万
  • 项目类别:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
研究微生物组和炎症在镰状细胞病患者急性和慢性疼痛中的作用
  • 批准号:
    9769125
  • 财政年份:
    2018
  • 资助金额:
    $ 16.69万
  • 项目类别:
Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell Disease
外周敏化作为镰状细胞病疼痛的新机制
  • 批准号:
    8720808
  • 财政年份:
    2013
  • 资助金额:
    $ 16.69万
  • 项目类别:
Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell Disease
外周敏化作为镰状细胞病疼痛的新机制
  • 批准号:
    8580484
  • 财政年份:
    2013
  • 资助金额:
    $ 16.69万
  • 项目类别:
Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell Disease
外周敏化作为镰状细胞病疼痛的新机制
  • 批准号:
    8849493
  • 财政年份:
    2013
  • 资助金额:
    $ 16.69万
  • 项目类别:

相似国自然基金

电针调控Nrf2表达抑制巨噬细胞铁死亡进程缓解急性痛风性关节炎疼痛的机制研究
  • 批准号:
    82305369
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
前扣带回沉默突触激活介导急性疼痛慢性化的环路和细胞机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
围术期睡眠剥夺激活外周感觉神经元芳香烃受体致术后急性疼痛慢性化
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
从急性到慢性下腰腿痛:默认网络对疼痛的编码作用及其机制的MRI研究
  • 批准号:
    82160331
  • 批准年份:
    2021
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

術後急性痛高リスク患者予測に基づく疼痛管理に関する介入研究
基于术后急性疼痛高危患者预测的疼痛管理干预研究
  • 批准号:
    24K12056
  • 财政年份:
    2024
  • 资助金额:
    $ 16.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients
高剂量与标准剂量流感疫苗在儿科实体器官移植受者中的比较
  • 批准号:
    10621099
  • 财政年份:
    2023
  • 资助金额:
    $ 16.69万
  • 项目类别:
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
同种异体肺移植受者中高剂量与标准剂量流感疫苗的比较
  • 批准号:
    10405753
  • 财政年份:
    2022
  • 资助金额:
    $ 16.69万
  • 项目类别:
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
同种异体肺移植受者中高剂量与标准剂量流感疫苗的比较
  • 批准号:
    10576411
  • 财政年份:
    2022
  • 资助金额:
    $ 16.69万
  • 项目类别:
患者の個別性をふまえた術後疼痛経過の予測モデル構築に関する研究
基于患者个体的术后疼痛过程预测模型构建研究
  • 批准号:
    21K10720
  • 财政年份:
    2021
  • 资助金额:
    $ 16.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了